ATE477806T1 - Verwendung hyperbarischer bedingungen zur bereitstellung von neuroprotektion - Google Patents
Verwendung hyperbarischer bedingungen zur bereitstellung von neuroprotektionInfo
- Publication number
- ATE477806T1 ATE477806T1 AT08736020T AT08736020T ATE477806T1 AT E477806 T1 ATE477806 T1 AT E477806T1 AT 08736020 T AT08736020 T AT 08736020T AT 08736020 T AT08736020 T AT 08736020T AT E477806 T1 ATE477806 T1 AT E477806T1
- Authority
- AT
- Austria
- Prior art keywords
- provide neuroprotection
- hyperbaric conditions
- conditions
- hyperbaric
- neuroprotection
- Prior art date
Links
- 230000004112 neuroprotection Effects 0.000 title abstract 2
- 229910052734 helium Inorganic materials 0.000 abstract 1
- 239000001307 helium Substances 0.000 abstract 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 229910052756 noble gas Inorganic materials 0.000 abstract 1
- 150000002835 noble gases Chemical class 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 229910052724 xenon Inorganic materials 0.000 abstract 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Eye Examination Apparatus (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07251539A EP1980260A1 (de) | 2007-04-10 | 2007-04-10 | Verwendung hyperbarischer Bedingungen zur Bereitstellung von Neuroprotektion |
| PCT/EP2008/054296 WO2008122654A2 (en) | 2007-04-10 | 2008-04-09 | Use of hyperbaric conditions to provide neuroprotection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE477806T1 true ATE477806T1 (de) | 2010-09-15 |
Family
ID=38162153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08736020T ATE477806T1 (de) | 2007-04-10 | 2008-04-09 | Verwendung hyperbarischer bedingungen zur bereitstellung von neuroprotektion |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100316729A1 (de) |
| EP (2) | EP1980260A1 (de) |
| JP (1) | JP2010523618A (de) |
| CN (1) | CN101795696A (de) |
| AT (1) | ATE477806T1 (de) |
| AU (1) | AU2008235414A1 (de) |
| CA (1) | CA2683569A1 (de) |
| DE (1) | DE602008002252D1 (de) |
| ES (1) | ES2348573T3 (de) |
| WO (1) | WO2008122654A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010040656A1 (en) * | 2008-10-06 | 2010-04-15 | L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Xenon-based gaseous anaesthetic to be administered via a heart lung machine |
| HUP0900431A2 (en) * | 2009-07-10 | 2011-01-28 | Cryo Innovation Kft | Sample imaging system and pocedure for transmitting imager of cells or tissues located in breeder space towards a data processing device |
| FR2964036B1 (fr) * | 2010-08-24 | 2013-04-12 | Air Liquide | Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications |
| CN103565745A (zh) | 2012-08-10 | 2014-02-12 | 德克萨斯州大学系统董事会 | 用于治疗中风的神经保护性脂质体组合物和方法 |
| EP4082552B1 (de) | 2013-03-15 | 2026-05-06 | The Board of Regents of the University of Texas System | Edelgasreiche flüssigkeiten sowie verfahren zu deren herstellung und verwendung |
| FR3007983B1 (fr) * | 2013-07-08 | 2015-06-26 | Air Liquide | Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative |
| WO2015034968A1 (en) | 2013-09-04 | 2015-03-12 | Microbaric Oxygen Systems, Llc | Hyperoxic therapy with oxygen dose-response model |
| US10058471B2 (en) | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
| FR3022456B1 (fr) * | 2014-06-20 | 2016-07-15 | Air Liquide | Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central |
| US20170341980A1 (en) * | 2016-05-31 | 2017-11-30 | Noblis Therapeutics, Inc. | Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4622976A (en) * | 1985-04-15 | 1986-11-18 | Enhancer R & D | Method and apparatus for conducting xenon inhalation studies |
| US5271401A (en) * | 1992-01-15 | 1993-12-21 | Praxair Technology, Inc. | Radiological imaging method |
| DE19910986C2 (de) * | 1999-03-11 | 2001-06-07 | Aga Ab | Verwendung von Xenon bei der Behandlung von Neurointoxikationen |
| GB9917822D0 (en) | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| GB0209998D0 (en) | 2002-05-01 | 2002-06-12 | Protexeon Ltd | Use |
| FR2863169B1 (fr) * | 2003-12-08 | 2006-02-10 | Air Liquide Sante Int | Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications |
| GB0418540D0 (en) | 2004-08-19 | 2004-09-22 | Protexeon Ltd | Use |
-
2007
- 2007-04-10 EP EP07251539A patent/EP1980260A1/de not_active Withdrawn
-
2008
- 2008-04-09 WO PCT/EP2008/054296 patent/WO2008122654A2/en not_active Ceased
- 2008-04-09 CN CN200880010825A patent/CN101795696A/zh active Pending
- 2008-04-09 ES ES08736020T patent/ES2348573T3/es active Active
- 2008-04-09 EP EP08736020A patent/EP2144616B1/de not_active Not-in-force
- 2008-04-09 CA CA002683569A patent/CA2683569A1/en not_active Abandoned
- 2008-04-09 AT AT08736020T patent/ATE477806T1/de not_active IP Right Cessation
- 2008-04-09 US US12/594,890 patent/US20100316729A1/en not_active Abandoned
- 2008-04-09 JP JP2010502502A patent/JP2010523618A/ja not_active Withdrawn
- 2008-04-09 DE DE602008002252T patent/DE602008002252D1/de active Active
- 2008-04-09 AU AU2008235414A patent/AU2008235414A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100316729A1 (en) | 2010-12-16 |
| CA2683569A1 (en) | 2008-10-16 |
| JP2010523618A (ja) | 2010-07-15 |
| CN101795696A (zh) | 2010-08-04 |
| EP1980260A1 (de) | 2008-10-15 |
| DE602008002252D1 (de) | 2010-09-30 |
| EP2144616A2 (de) | 2010-01-20 |
| WO2008122654A3 (en) | 2009-02-05 |
| EP2144616B1 (de) | 2010-08-18 |
| WO2008122654A2 (en) | 2008-10-16 |
| ES2348573T3 (es) | 2010-12-09 |
| AU2008235414A1 (en) | 2008-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602008002252D1 (de) | Verwendung hyperbarischer bedingungen zur bereitstellung von neuroprotektion | |
| MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
| WO2008057217A3 (en) | Spinal cross connectors | |
| WO2007110231A3 (en) | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES | |
| DK1773361T4 (da) | Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme | |
| ATE531383T1 (de) | Therapeutische verwendung eines wachstumsfaktors, metrnl | |
| DE602004022419D1 (de) | Zwischenlaminae wirbelsäulenprothese | |
| IL190796A0 (en) | Compositions and their uses for gene therapy of bone conditions | |
| DK1687049T3 (da) | Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer | |
| IL211085A0 (en) | Perfusion solution | |
| DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
| CL2008002954A1 (es) | Compuestos derivados de 1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahidrociclopenta-(5,6)nafto-(1,2-f)indazol heterociclo o carbociclo sustituido; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento de asma, epoc, rinits alergica. | |
| BRPI0508629A (pt) | trilho lateral para uso com um suporte para paciente | |
| EP2052707B8 (de) | Bett, insbesondere Kranken- oder Pflegebett, mit teilweise absenkbaren Seiten- und/oder Kopf- bzw. Fußteilen | |
| TW200517107A (en) | Novel formulation | |
| NO20065536L (no) | Behandling av astma hos barn | |
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| ATE367167T1 (de) | Aufbereitung von aldesleukin zur pharmazeutischen verwendung | |
| NO20055692L (no) | Intravenos injeksjon av ikkeneurotoksiske plasminogenaktivatorer til behandling av cerebralt slag | |
| BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
| ATE527377T1 (de) | Erstellung von genexpressionprofilen aus ffpe- proben | |
| JO2662B1 (en) | Use of 4-cyclopropylmethoxy -N-(3,5-dichloro-1-oxido-4-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide in the treatment of spinal cord traumas | |
| TW200728295A (en) | Benzochromene derivatives | |
| IL177169A0 (en) | Use of n- (2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury | |
| IL182297A (en) | Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |